Skip to main content
TipRanks
Go Ultimate75% OFF

Knight Therapeutics (KHTRF) Stock Forecast & Price Target

33 Followers
See the Price Targets and Ratings of:

KHTRF Analyst Ratings

Strong Buy
3Ratings
3Buy0Hold0Sell
Based on 3 analysts giving stock ratings to Knight Therapeutics in the past 3 months

KHTRF Stock 12 Month Forecast

$9.09▲(7.93% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Knight Therapeutics in the last 3 months. The average price target is $9.09 with a high forecast of $9.21 and a low forecast of $9.03. The average price target represents a 7.93% change from the last price of $8.42.
Highest Price Target$9.21Average Price Target$9.09Lowest Price Target$9.03

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for KHTRF
Price TargetArticle
RBC Capital$7.79→$9.21buy9.33%UpsideReiterated11/06/26
Stifel Nicolaus$8.68→$9.03buy7.23%UpsideReiterated11/06/26
Canaccord Genuity$7.79→$9.03buy7.23%UpsideReiterated11/06/26
Bloom Burton$8.50buy0.92%UpsideReiterated08/07/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PTGXProtagonist Therapeutics
ESTAEstablishment Labs Holdings
MDWDMediwound
IMUXImmunic
OVIDOvid Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Knight Therapeutics

3 Months
Justin Keywood
Justin KeywoodStifel Nicolaus
Success Rate10/13 ratings generated profit
77%
Average Return
+8.30%

Copying Justin Keywood's trades and holding each position for 3 Months would result in 76.92% of your transactions generating a profit, with an average return of +8.30% per trade.

1 Year
Justin Keywood
Justin KeywoodStifel Nicolaus
Success Rate12/13 ratings generated profit
92%
Average Return
+36.69%

Copying Justin Keywood's trades and holding each position for 1 Year would result in 92.31% of your transactions generating a profit, with an average return of +36.69% per trade.

2 Years
Justin Keywood
Justin KeywoodStifel Nicolaus
Success Rate12/13 ratings generated profit
92%
Average Return
+64.75%

Copying Justin Keywood's trades and holding each position for 2 Years would result in 92.31% of your transactions generating a profit, with an average return of +64.75% per trade.

KHTRF Analyst Recommendation Trends

02468Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for KHTRF
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy00000
Buy43344
Hold00000
Sell00000
Strong Sell00000
total43344

In the current month, KHTRF has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. KHTRF average Analyst price target in the past 3 months is 9.09.

KHTRF Financial Forecast

$-2$-1.25$-0.5$0.25$1Q1 2026Q3 2026Q4 2026
High$0.09
Consensus$0.04
Low$0.01

KHTRF Earnings Forecast

Next quarter’s earnings estimate for KHTRF is $0.04 with a range of $0.01 to $0.09. The previous quarter’s EPS was -$0.02. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$91.6M$94.9M$98.1M$101.4M$104.6MQ1 2026Q3 2026Q4 2026
High$99M
Consensus$95.3M
Low$91.6M

KHTRF Sales Forecast

Next quarter’s sales forecast for KHTRF is $95.28M with a range of $91.62M to $99.01M. The previous quarter’s sales results were $97.04M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

KHTRF Stock Forecast FAQ

What is KHTRF’s average 12-month price target, according to analysts?
Based on analyst ratings, Knight Therapeutics’s 12-month average price target is $9.09.
What is KHTRF’s upside potential, based on the analysts’ average price target?
Knight Therapeutics has 7.93% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is KHTRF a Buy, Sell or Hold?
Knight Therapeutics has a consensus rating of Strong Buy which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is Knight Therapeutics’s price target?
The average price target for Knight Therapeutics is $9.09. This is based on 3 12-month price targets, issued in the past 3 months. The highest analyst price target is $9.21, the lowest forecast is $9.03. The average price target represents a 7.93% increase from the current price of $8.425.
What do analysts say about Knight Therapeutics?
Knight Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of KHTRF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.